NEW YORK, Dec. 29, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Tikcro Technologies Ltd. (OTCQX: TIKRF), an Israel-based developer of second generation antibodies binding to cancer-immune modulators, currently in pre-clinical stage, has qualified to trade on the OTCQX® Best Market.
Tikcro begins trading today on OTCQX under the symbol "TIKRF." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We are thrilled to welcome Tikcro to our growing family of investor-focused U.S. and international companies on the OTCQX market," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "Trading on OTCQX will enable Tikcro to expand its visibility in the U.S. market through transparent trading and convenient access to its news and financial disclosure. We look forward to helping the company grow and prosper."
Aviv Boim, CEO of Tikcro Technologies, said, "Trading on OTCQX marks another milestone for our plan to deliver next generation therapeutic antibodies for cancer immune therapy treatment. We see continuous strong clinical data and revenue growth in this field. Our unique approach for generating new antibodies is expected to result in functional and highly selective antibodies, addressing CTLA-4, PD1 and TIGIT pathways. In 2016, we intend to further validate our antibody drug candidates in pre-clinical trials. We look forward to have our ordinary shares available to investors on the OTCQX market."
Berns & Berns serves as Tikcro's Principal American Liaison ("PAL") on OTCQX, responsible for providing professional guidance on OTCQX requirements.
Tikcro supports early stage development in growth areas, with a focus on biotechnology projects originated in Israeli academic centers. Tikcro is currently engaged with development of certain antibodies selected and verified in pre-clinical trials with a focus on antibodies binding to cancer immune modulators pathways. For more information about Tikcro, visit Tikcro's website at www.tikcro.com.
About OTC Markets Group
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, firstname.lastname@example.org
SOURCE OTC Markets Group Inc.